Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Form 4 today - Brent bought 50K more shares at 62 cents on Friday 1/4/19. He now owns 1,832K shares. Putting his money where his mouth is.
Look at AAPL on that site too! It appears massive naked shorts are there too. You really believe that?
That site NEVER showed a short closing a position. That "data" is worthless.
Just received my book entry statement from natco for AtoZ shares.
Natco has my account and address listed for the spin-off shares (Fidelity Brokerage).
Also, IR says transcript of Tuesday conference call will be on website in a few days.
PRED owns a little over 50% of Juneau.
Our ARTguide™ test was developed by Juneau Biosciences, LLC. We currently own just over fifty percent of Juneau. We have an exclusive license with Juneau to market Juneau’s patented molecular diagnostics for use in the prognosis and monitoring of endometriosis in the infertility and
pelvic pain markets
Barry is totally clueless. He and Cramer are a real pair.
Not a reporting company until now so no need to report insider buying.
LOL - oh okay
I don't think that number is too far off. Diagnostic products + tissue sales could get us close.
My guess is that they will not do a secondary offering until the stock is at least $8/share (hopefully $10). Otherwise the dilution would be too much for current shareholders including the people in the company. They don't want to screw themselves.
The presentation will be very similar unless they do a PR tomorrow.
Not exactly sure. Hopefully sometime in December.
Nice summary Chris. The naked short position isn't anywhere near what people on this board think it is. Maybe 500K shares - that's about it. If they look at Apple for "naked short" position you would be lead to believe half the float is short-LOL.
They have been very secretive about what they are doing. Once the form 10 comes out (I am told it is very lengthy) more news will follow. Meanwhile take advantage of these low prices.
Loaded up here. Increased long position by 200%. Thanks for the super cheap shares! Adding more < $1
At this point, PRED is only trading around 10% of its patent value. Bargain basement pricing.
Or they are doing it now. Some people like to sell and then buy back after 30 days (tax loss allowed) but before a year end rally (if there is one) and before the new year. Different strategies in play.
Could do much more than $100M - depends on diagnostic tests roll out.
C'mon WEYL, go below $1. I want super cheap shares.
The pot grow and processing facilities is my reason. Lighting and fertilizer products would be secondary. The pot processes will produce a vast majority of the profitability starting next year.
Expecting $25M revenue this year and more than double that next year.
Except to see earnings for calendar Q3 this week. That is their typical timeframe.
Waiting for sub $1 double bottom. Naked short size is over exaggerated.
Don't forget - WEYL will still own 51% of the AtoZ business after the spin-off shares.
Next support 57 cents; after that 40 cents.
Fidelity has the info
Don't forget - it hasn't even reached the January highs and the story only gets better.
How do we know there really is a naked short sale interest of 4M shares? The OTC Short report https://www.otcshortreport.com/company/WEYL doesn't tell you when or if a naked short position has been closed via a purchase. I can't find anywhere you can get the number.
The company is now selling LED fixtures. Looking forward to a much better 2nd half.
Decent close considering.
I believe they will need to sell a substantial number of shares to fund the AZ effort and get thru the next year (to mid-2019). Currently 44-45M shares outstanding.
Someone messed up a 1000 share sell order.
No and definitely not on that analyst.
Alan and co. did a bad job communicating the new strategy and revised outlook to the investment community. Future growth will be very strong here (and profitable with high margins) but you would never know it by a stock price of 85 cents.
According to TipRanks.com, Ram Selvaraju is a 3-star analyst with an average return of 2.4% and a 39.4% success rate.
In other words, you are better off with a coin flip.
If they are really valuing Consensi at $110M; how do they come up with a 12.50/share price target? That anal-yst is weak.
Broke out of a 7 day wedge... BULLISH ... on strong volume
I agree. Most people don't know what is really going on here. The LD presentation is good indicator for people that listened closely.
Wow - we actually had an UP day????
Anyone interested in $pred needs to listen to this Critical piece is from 9mins to 11 mins when it details that if they are in only 12 clinics with 9 docs per clinic doing 35 prescriptions then the revenue is $150 M per year https://t.co/7dTUh4Zxo6
— Hopespringseternal (@Stockguru8) June 8, 2018